On Oct 29, 2025, OPK reported earnings of 0.03 USD per share (EPS) for Q3 25, beating the estimate of -0.04 USD, resulting in a 165.93% surprise. Revenue reached 151.70 million, compared to an expected 162.39 million, with a -6.58% difference. The market reacted with a +2.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 141.15 million USD, implying an decrease of -300.00% EPS, and decrease of -6.95% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
What were Opko Health Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Opko Health Inc. reported EPS of $0.03, beating estimates by 165.93%, and revenue of $151.70M, -6.58% below expectations.
How did the market react to Opko Health Inc.'s Q3 2025 earnings?
The stock price moved up 2.1%, changed from $1.43 before the earnings release to $1.46 the day after.
When is Opko Health Inc. expected to report next?
The next earning report is scheduled for Feb 19, 2026.
What are the forecasts for Opko Health Inc.'s next earnings report?
Based on 8
analysts, Opko Health Inc. is expected to report EPS of -$0.06 and revenue of $141.15M for Q4 2025.